Neomycin sulfate

73 Cited Publications
Kundenbewertung

Based on 73 publication(s) in Google Scholar

Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis. Neomycin sulfate inhibits IP3-mediated Ca2+ release, MgATP-dependent Ca2+ uptake, and electrical excitation-evoked skeletal muscle Ca2+ transients. Neomycin sulfate depletes gut microbiota in specific mouse models, causes hearing impairment, and kidney damage with prolonged exposure. Neomycin sulfate can be used for the research of cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.86%
  • CAS. Nr.: 1405-10-3
  • Formel: C23H52N6O25S3
  • Molecular Weight:908.88
  • Speicherung:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Neomycin sulfate

More
Customer Validation & Images
In Vivo Efficacy StudyPK/PD AnalysisOthersBio/Physico-chemical Assay
  • In Vivo Efficacy Study
  • Others
  • PK/PD Analysis
  • Bio/Physico-chemical Assay

Alle Phospholipase Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00